All-trans retinoic acid in adult chronic myelomonocytic leukemia: Results of a pilot study

Leukemia

Volumn 10, Issue 7, 1996, Pages 1164-1167

  Cambier, N ^a,b   Wattel, E ^b   Menot, M L ^a   Guerci, A ^c   Chomienne, C ^a   Fenaux, P ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Retinoids

Indexed keywords

HYDROXYUREA; RETINOIC ACID;

ARTICLE; BONE MARROW CELL; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT C; COLONY FORMING UNIT M; FATALITY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MONONUCLEAR CELL; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE COUNT;

EID: 0030054965     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Castro-Malaspina H, Schaison G, Passe S. Subacute and chronic myelomonocytic leukemia in children (juvenile CML): clinical and hematologic observations, and identification of prognostic factors. Cancer 1984; 54: 675-686.
2. Freedman MH, Estrey H. Juvenile chronic myelogenous leukemia. Am J Ped Hem/Oncol 1988; 10: 261-267.
3. Estrow Z, Grunberger T, Schan HSL, Freedman MH. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood 1986; 67: 1382-1387.
4. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony stimulating factor by juvenile chronic myelogenous leukemia hematopoietic progenitors. Blood 1991; 77: 925-928.
5. Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML, Dickerman JD, Hakami N, Castleberry RP. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 1989; 74: 2360-2367.
6. Emanuel PD, Zuckerman KS, Wimmer R, Cohn S, Chaffee S, Castleberry RP. In vivo 13-cis retinoic acid therapy decreases the in vitro GM-CSF hypersensitivity in juvenile chronic myelogenous leukemia (JCML). Blood 1991; 78 (Suppl. 1): 170a abstr.
7. Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd R, Homan A, Chaffee S, Nitschke R, Gualtieri R. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 1994; 331: 1680-1684.
8. Bennett JM, Catovsky D, Daniel MT (FAB cooperative group). Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
9. Worsley A, Mufti G, Stevens J, Oscier D, Hamblin T. Chronic myelomonocytic leukemia. A modified Bournemouth score gives the best prediction of survival. Br J Haematol 1988; 68: 17-21.
10. Fenaux P, Beuscart R, Jouet JP, Bauters F. Prognostic factors in adult chronic myelomonocytic leukemia: J Clin Oncol 1988; 6: 1417-1424.
11. Tefferi A, Hoahland H, Therneau T, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc 1989; 64: 1246-1254.
12. Dresh C, Faille A, Poirier O. Bone marrow cell kinetics and culture in chronic and subacute myelomonocytic leukemia. Physiopathological interpretation and prognostic importance. Leuk Res 1979; 4: 129-133.
13. Yuo A, Miyazono K, Takaku F. Characterization of granulocytemacrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders. Jap J Cancer Res 1990; 81: 820-826.
14. Everson MP, Brown CB, Lilly MB. Interleukin 6 and granulocyte macrophage colony stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells. Blood 1989; 74: 1472-1476.
15. Akashi K, Shibuya T, Harada M. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J Clin Invest 1991; 88: 223-230.
16. Valtieri M, Boccoli G, Testa U, Barletta C, Peschle C. Two-step differentiation of AML 193 leukemic line: terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony-stimulating factor (CSF) and vitamin D3 with monocyte CFS. Blood 1991; 77: 1804-1812.
17. Iscove NN, Seen JS, Till JE, McCulloch EA. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. Blood 1971; 37: 1-8.
18. Gold EJ, Mertelmann RH, Itri LM, Gee T, Arlin Z, Kempin S, Clarkson B, Moore MAS. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat 1983; 69: 981-986.
19. Greenberg BR, Durie BD, Barnett TC, Meyskens FL. Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat 1985; 67: 369-374.
20. Aul C, Runde V, Gattermann N. All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. Blood 1993; 82: 2967-2974.
21. Koeffler HP, Heitjan D, Mertelsman R, Kolitz JE, Shulman P, Itri L, Gunter P, Besa E. Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. Blood 1988; 71: 703-708.
22. Ohno R, Naoe T, Hirano M. Treatment of myelodysplastic syndromes with all-trans retinoic acid. Blood 1993; 81: 1152-1154.
23. Kurzrock R, Estey E, Talpaz M. All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndromes. J Clin Oncol 1993; 11: 1489-1495.
24. Clark RE, Jacobs A, Lush CJ, Smith SA. Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndromes. Lancet 1987; 1: 763-765.
25. Dubois C, Schlageter MH, De Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 1994; 8: 1750-1757.
26. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell R. The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292-301.
27. Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, Castaigne S, Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 82: 2643-2653.
28. Gratas C, Menot ML, Dresh C, Chomienne C. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 1993; 7: 1156-1162.
29. Sakashita A, Nakamaki T, Tsuruoka N, Honma Y, Hozumi M. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor acts with retinoic acid to form functional N-formy-methionyl-phenylalanine receptors in HL-60 cells. Leukemia 1991; 5: 26-31.